Form D Explorer

Inspect source fieldsReport a record issue

Form D — Vesalius Longevity Labs Inc.

0002060755-26-000064 · filed Nov 3, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
06b
Reported offering amount
$30,112,500
Reported amount sold
$30,112,500
Minimum investment
$0
Investors
62
Sales commission
$0
Finders' fees
$0

Issuer

Name
Vesalius Longevity Labs Inc.
CIK
2131865
Entity
Corporation
Jurisdiction
BRITISH COLUMBIA, CANADA
Year incorporated
—
Address
SUITE 1500-1055 WEST GEORGIA STREET
VANCOUVER, A1 V6E 4N7
Phone
604-307-8290

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗